Semler Scientific (NASDAQ:SMLR - Get Free Report) is scheduled to be releasing its earnings data after the market closes on Monday, November 4th. Persons that wish to register for the company's earnings conference call can do so using this link.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.08. The company had revenue of $14.47 million for the quarter. Semler Scientific had a return on equity of 21.17% and a net margin of 25.62%.
Semler Scientific Trading Up 7.8 %
SMLR traded up $2.15 on Monday, hitting $29.57. 242,447 shares of the company's stock traded hands, compared to its average volume of 184,781. The company's 50 day simple moving average is $25.74 and its 200-day simple moving average is $28.46. The firm has a market cap of $206.69 million, a price-to-earnings ratio of 14.41 and a beta of 0.96. Semler Scientific has a one year low of $20.88 and a one year high of $53.38.
Insider Activity at Semler Scientific
In other Semler Scientific news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the firm's stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.35, for a total transaction of $283,500.00. Following the completion of the transaction, the chief executive officer now owns 60,220 shares in the company, valued at $1,707,237. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 30.20% of the stock is owned by corporate insiders.
About Semler Scientific
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
